Brief: Teleflex Announces FDA Breakthrough Device Designation For Freesolve Resorbable Magnesium Scaffold
Today 12:53
BRIEF-Teleflex Announces FDA Breakthrough Device Designation For Freesolve Resorbable Magnesium Scaffold Oct 22 (Reuters) - Teleflex Incorporated TFX.N:
TELEFLEX ANNOUNCES FDA BREAKTHROUGH DEVICE DESIGNATION FOR FREESOLVE™ RESORBABLE MAGNESIUM SCAFFOLD
Source text: ID:nBw2bLpKQa
Further company coverage: TFX.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Teleflex Incorporated
See all newsBrief: Teleflex Announces FDA Breakthrough Device Designation For Freesolve Resorbable Magnesium Scaffold
Brief: UK's CMA Issues Invitation to Comment on Intersurgical-Teleflex Transaction
Competition and Mkts - Merger Update: Intersurgical / Teleflex
Teleflex Incorporated reports results for the quarter ended June 30 - Earnings Summary
Teleflex Q2 revenue rises 29%, beats analyst estimates